SCHEMBL5753422

SCHEMBL5753422

O=C(O)c1cc([N+](=O)[O-])cc2c(O)nc(O)nc12

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 3/20 0.48
▸ MAPK1 P28482 1/20 0.48
▸ PTPN1 P18031 2/20 0.41
▸ ALDH1A1 P00352 6/20 0.39
▸ TDP1 Q9NUW8 3/20 0.39
▸ CA1 P00915 1/20 0.39
▸ CA2 P00918 1/20 0.39
▸ CYP3A4 P08684 1/20 0.39
▸ ALOX15 P16050 1/20 0.39
▸ SMN1; SMN2 Q16637 2/20 0.37
▸ TP53 P04637 1/20 0.37
▸ HTT P42858 1/20 0.37
▸ CTSV O60911 1/20 0.37
▸ CTSL P07711 1/20 0.37
▸ PIM1 P11309 1/20 0.36
▸ AKR1B1 P15121 1/20 0.36
▸ KMT2A Q03164 1/20 0.36
▸ MAOA P21397 1/20 0.36
▸ MAOB P27338 1/20 0.36
▸ CYP1A2 P05177 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5754880 0.83 ALDH1A1 (0.38) MAPTALDH1A1SMN1; SMN2HTTKMT2A
SCHEMBL5756956 0.79 NQO2 (0.50) MAPTMAPK1ALDH1A1TDP1CYP3A4
SCHEMBL5753538 0.77 MAPT (0.44) MAPTMAPK1ALDH1A1CYP3A4ALOX15
SCHEMBL5753186 0.76 PIN1 (0.45) MAPTTDP1CTSVCTSLPIM1
SCHEMBL5754027 0.74 MEN1 (0.49) MAPTMAPK1TDP1CA1CA2
SCHEMBL5753717 0.72 HTT (0.33) MAPTALDH1A1TDP1SMN1; SMN2HTT
SCHEMBL5971372 0.71 AKR1B1 (0.52) MAPTMAPK1ALDH1A1TDP1CA1
SCHEMBL5756942 0.71 KMT2A (0.38) MAPTALDH1A1KMT2A
SCHEMBL5755645 0.70 KMT2A (0.40) MAPTALDH1A1TDP1HTTKMT2A
SCHEMBL11420063 0.69 ALDH1A1 (0.49) MAPTMAPK1PTPN1ALDH1A1TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1218358-B1 THERAPEUTIC QUINAZOLINE COMPOUNDS ASTRAZENECA AB (SE) 2006-09-13 — — EP disclosed
EP-1218358-A1 THERAPEUTIC QUINAZOLINE COMPOUNDS AstraZeneca AB (SE) 2002-07-03 — — EP disclosed
US-6399603-B1 QUINAZOLINES; RETARDING APOPTOSIS IN CELLS; INHIBITING CLEAVAGE OF PROTEIN SUBSTRATES BY CASPASE-3; CHEMICAL AND HYDROLYTIC STABILITY ASTRAZENECA AB (SE) 2002-06-04 — — US disclosed
WO-2001021598-A1 THERAPEUTIC QUINAZOLINE COMPOUNDS ASTRAZENECA AB (SE) 2001-03-29 — — WO disclosed
Send feedback